معرفی
Peter Marckmann is a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences, specializing in Internal Medicine with a focus on Nephrology. He is affiliated with Sjællands Universitetshospital (Zealand University Hospital) in Roskilde, Denmark, where he conducts clinical research and patient care. His institutional email is pmar@regionsjaelland.dk, and his academic profile is hosted on the University of Copenhagen's website.
Dr. Marckmann's research primarily centers on nephrology with specific emphasis on vitamin K metabolism in dialysis patients, bone mineral density, vascular calcification, and nutritional aspects of chronic kidney disease. His work bridges clinical practice with epidemiological research, examining how dietary patterns and micronutrient supplementation affect outcomes in renal patients. He has led the significant RenaKvit trial, a double-blind, randomized, placebo-controlled study investigating vitamin K supplementation in dialysis patients, which has generated multiple high-impact publications across nephrology and nutrition journals.
Analysis of his publication record from 2016-2024 reveals a consistent research trajectory focused on metabolic complications of kidney disease, particularly the interplay between vitamin K status, bone health, and vascular outcomes in dialysis populations. His work spans clinical trials, systematic reviews, and population-based epidemiological studies, demonstrating methodological versatility. Several publications have garnered substantial attention, with one 2018 review on vitamin D supplementation accumulating 72 Scopus citations and being referenced in clinical guidelines, while the 2021 RenaKvit trial on arterial calcification received 37 citations and was referenced in two clinical guideline sources.
Dr. Marckmann's research has achieved notable dissemination, with multiple publications picked up by news outlets, blogged about, and shared across social media platforms including X (formerly Twitter) and Reddit. His work on vitamin K supplementation in dialysis patients has been particularly influential, appearing in high-impact nephrology journals including Nephrology Dialysis Transplantation and Clinical Kidney Journal. The RenaKvit trial represents a significant contribution to understanding how vitamin K metabolism affects complications in end-stage renal disease.
